Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiovascular Diseases | 33 | 2021 | 402 | 4.790 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 12 | 2021 | 63 | 2.560 |
Why?
|
Life Style | 15 | 2020 | 211 | 2.300 |
Why?
|
Exercise | 21 | 2023 | 468 | 2.240 |
Why?
|
Health Promotion | 11 | 2021 | 161 | 1.730 |
Why?
|
Cholesterol | 6 | 2021 | 50 | 1.400 |
Why?
|
Hypercholesterolemia | 7 | 2021 | 29 | 1.220 |
Why?
|
Coronary Disease | 6 | 2010 | 86 | 1.080 |
Why?
|
Anticholesteremic Agents | 8 | 2021 | 18 | 1.070 |
Why?
|
Primary Prevention | 6 | 2021 | 38 | 0.990 |
Why?
|
Risk Factors | 19 | 2020 | 2443 | 0.990 |
Why?
|
Cardiology | 7 | 2018 | 73 | 0.900 |
Why?
|
Health Behavior | 6 | 2021 | 159 | 0.850 |
Why?
|
Risk Reduction Behavior | 8 | 2018 | 55 | 0.850 |
Why?
|
Humans | 75 | 2023 | 29337 | 0.810 |
Why?
|
Risk Assessment | 14 | 2021 | 679 | 0.740 |
Why?
|
Guidelines as Topic | 2 | 2019 | 67 | 0.740 |
Why?
|
Hypertension | 9 | 2016 | 266 | 0.700 |
Why?
|
United States | 20 | 2023 | 2333 | 0.670 |
Why?
|
ST Elevation Myocardial Infarction | 1 | 2018 | 10 | 0.650 |
Why?
|
Practice Guidelines as Topic | 8 | 2019 | 333 | 0.630 |
Why?
|
Biomarkers | 9 | 2021 | 689 | 0.620 |
Why?
|
Dyslipidemias | 5 | 2021 | 23 | 0.620 |
Why?
|
Societies, Medical | 1 | 2019 | 190 | 0.620 |
Why?
|
Myocardial Infarction | 1 | 2018 | 172 | 0.590 |
Why?
|
Patient Selection | 4 | 2018 | 232 | 0.570 |
Why?
|
Medication Adherence | 2 | 2015 | 78 | 0.550 |
Why?
|
Patient Compliance | 4 | 2016 | 164 | 0.540 |
Why?
|
Benchmarking | 4 | 2011 | 41 | 0.530 |
Why?
|
Patient Participation | 1 | 2015 | 52 | 0.520 |
Why?
|
Middle Aged | 31 | 2021 | 9823 | 0.520 |
Why?
|
Global Health | 3 | 2011 | 55 | 0.520 |
Why?
|
Social Environment | 1 | 2015 | 79 | 0.520 |
Why?
|
Aged | 28 | 2020 | 9448 | 0.510 |
Why?
|
Adult | 29 | 2019 | 8601 | 0.500 |
Why?
|
Hyperlipidemias | 4 | 2018 | 19 | 0.500 |
Why?
|
Female | 36 | 2023 | 16197 | 0.500 |
Why?
|
Diet, Fat-Restricted | 2 | 2012 | 6 | 0.490 |
Why?
|
Coronary Artery Disease | 4 | 2021 | 123 | 0.460 |
Why?
|
Cholesterol, LDL | 5 | 2021 | 30 | 0.450 |
Why?
|
Evidence-Based Medicine | 5 | 2018 | 208 | 0.440 |
Why?
|
Practice Patterns, Nurses' | 2 | 2016 | 17 | 0.440 |
Why?
|
Motor Activity | 7 | 2014 | 369 | 0.440 |
Why?
|
Secondary Prevention | 3 | 2021 | 64 | 0.410 |
Why?
|
Health Education | 1 | 2011 | 39 | 0.400 |
Why?
|
Ezetimibe | 3 | 2021 | 4 | 0.400 |
Why?
|
Motivation | 3 | 2021 | 100 | 0.370 |
Why?
|
1-Alkyl-2-acetylglycerophosphocholine Esterase | 1 | 2010 | 2 | 0.370 |
Why?
|
Nurses | 3 | 2021 | 46 | 0.370 |
Why?
|
Hypertriglyceridemia | 1 | 2010 | 20 | 0.370 |
Why?
|
Workplace | 2 | 2021 | 18 | 0.360 |
Why?
|
Healthy Lifestyle | 2 | 2021 | 28 | 0.360 |
Why?
|
Health Status | 3 | 2021 | 227 | 0.360 |
Why?
|
Medical Errors | 2 | 2021 | 28 | 0.360 |
Why?
|
Diet, Mediterranean | 1 | 2010 | 62 | 0.350 |
Why?
|
Nurse Clinicians | 1 | 2009 | 25 | 0.350 |
Why?
|
Medical Order Entry Systems | 1 | 2008 | 3 | 0.340 |
Why?
|
Primary Health Care | 2 | 2020 | 96 | 0.330 |
Why?
|
Self Care | 1 | 2009 | 90 | 0.330 |
Why?
|
Mental Health | 2 | 2021 | 105 | 0.320 |
Why?
|
Attitude of Health Personnel | 1 | 2009 | 148 | 0.320 |
Why?
|
Referral and Consultation | 1 | 2008 | 86 | 0.320 |
Why?
|
Patient Education as Topic | 4 | 2011 | 162 | 0.310 |
Why?
|
Heart Diseases | 1 | 2008 | 73 | 0.310 |
Why?
|
Women's Health Services | 2 | 2018 | 12 | 0.310 |
Why?
|
Education, Nursing, Graduate | 2 | 2023 | 89 | 0.310 |
Why?
|
Blood Pressure | 8 | 2015 | 238 | 0.310 |
Why?
|
Health Services Accessibility | 3 | 2020 | 101 | 0.300 |
Why?
|
Male | 21 | 2020 | 15621 | 0.280 |
Why?
|
Patient Acceptance of Health Care | 2 | 2020 | 79 | 0.280 |
Why?
|
Patient Care Team | 2 | 2019 | 140 | 0.270 |
Why?
|
Cardiac Rehabilitation | 1 | 2005 | 9 | 0.270 |
Why?
|
Obesity | 4 | 2016 | 291 | 0.260 |
Why?
|
Cross-Sectional Studies | 6 | 2021 | 959 | 0.260 |
Why?
|
Clinical Decision-Making | 3 | 2021 | 36 | 0.260 |
Why?
|
American Heart Association | 5 | 2021 | 29 | 0.260 |
Why?
|
Atherosclerosis | 2 | 2018 | 72 | 0.260 |
Why?
|
Women's Health | 3 | 2018 | 246 | 0.240 |
Why?
|
National Institute of Nursing Research (U.S.) | 1 | 2023 | 7 | 0.230 |
Why?
|
Self Efficacy | 2 | 2021 | 57 | 0.220 |
Why?
|
Lipoprotein(a) | 2 | 2016 | 5 | 0.220 |
Why?
|
Surveys and Questionnaires | 6 | 2021 | 1184 | 0.210 |
Why?
|
Social Support | 2 | 2021 | 185 | 0.210 |
Why?
|
Chicago | 5 | 2016 | 865 | 0.210 |
Why?
|
Cognitive Dysfunction | 2 | 2020 | 938 | 0.210 |
Why?
|
Military Medicine | 1 | 2021 | 14 | 0.210 |
Why?
|
Treatment Outcome | 9 | 2021 | 3478 | 0.200 |
Why?
|
Palliative Care | 2 | 2020 | 145 | 0.200 |
Why?
|
Qualitative Research | 2 | 2019 | 112 | 0.190 |
Why?
|
Muscle, Skeletal | 2 | 2017 | 349 | 0.190 |
Why?
|
Exercise Therapy | 2 | 2008 | 112 | 0.190 |
Why?
|
Quality of Life | 3 | 2020 | 662 | 0.190 |
Why?
|
Endothelium | 1 | 2020 | 12 | 0.190 |
Why?
|
Heart Transplantation | 1 | 2020 | 38 | 0.180 |
Why?
|
Residence Characteristics | 3 | 2016 | 216 | 0.180 |
Why?
|
Preventive Medicine | 1 | 2019 | 12 | 0.180 |
Why?
|
Vascular Diseases | 1 | 2020 | 48 | 0.180 |
Why?
|
Insurance Coverage | 1 | 2019 | 13 | 0.180 |
Why?
|
Counseling | 2 | 2010 | 48 | 0.180 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2019 | 4 | 0.180 |
Why?
|
Physician-Patient Relations | 1 | 2019 | 39 | 0.180 |
Why?
|
Prognosis | 4 | 2018 | 840 | 0.170 |
Why?
|
Nurse's Role | 2 | 2011 | 118 | 0.170 |
Why?
|
Physical Endurance | 3 | 1997 | 12 | 0.170 |
Why?
|
Consensus | 4 | 2021 | 105 | 0.170 |
Why?
|
Posture | 1 | 1999 | 78 | 0.170 |
Why?
|
Adolescent | 5 | 2015 | 2279 | 0.170 |
Why?
|
Decision Support Techniques | 1 | 2018 | 52 | 0.170 |
Why?
|
Heart Failure | 2 | 2020 | 202 | 0.160 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2018 | 26 | 0.160 |
Why?
|
Marital Status | 1 | 2018 | 15 | 0.160 |
Why?
|
Ambulatory Care Facilities | 1 | 2018 | 37 | 0.160 |
Why?
|
Occupational Health | 1 | 2018 | 21 | 0.160 |
Why?
|
Antihypertensive Agents | 1 | 2018 | 85 | 0.160 |
Why?
|
Blogging | 1 | 2017 | 2 | 0.160 |
Why?
|
Program Evaluation | 2 | 2015 | 132 | 0.160 |
Why?
|
Information Storage and Retrieval | 1 | 2017 | 5 | 0.160 |
Why?
|
Muscular Diseases | 1 | 2017 | 18 | 0.160 |
Why?
|
Practice Patterns, Physicians' | 1 | 2018 | 132 | 0.150 |
Why?
|
Sex Characteristics | 1 | 2018 | 132 | 0.150 |
Why?
|
Quality Improvement | 1 | 2018 | 158 | 0.150 |
Why?
|
Self Concept | 1 | 1997 | 45 | 0.150 |
Why?
|
Prevalence | 4 | 2016 | 487 | 0.150 |
Why?
|
Diabetes Mellitus, Type 2 | 2 | 2011 | 200 | 0.140 |
Why?
|
Age Factors | 3 | 2018 | 843 | 0.140 |
Why?
|
Smoking | 2 | 2007 | 194 | 0.140 |
Why?
|
Health Expenditures | 1 | 2015 | 19 | 0.140 |
Why?
|
Patient Dropouts | 1 | 2015 | 27 | 0.140 |
Why?
|
Evidence-Based Nursing | 1 | 2016 | 25 | 0.140 |
Why?
|
Cognition | 2 | 2020 | 1277 | 0.140 |
Why?
|
Patient-Centered Care | 1 | 2015 | 62 | 0.130 |
Why?
|
Catecholamines | 1 | 1994 | 13 | 0.130 |
Why?
|
Physical Fitness | 2 | 1994 | 59 | 0.130 |
Why?
|
Cardiac Output | 1 | 1994 | 21 | 0.130 |
Why?
|
Cardiomegaly | 1 | 1994 | 13 | 0.130 |
Why?
|
Nutritional Sciences | 1 | 2014 | 7 | 0.120 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 328 | 0.120 |
Why?
|
Adaptation, Physiological | 1 | 1994 | 55 | 0.120 |
Why?
|
Spouses | 1 | 2014 | 25 | 0.120 |
Why?
|
Geriatric Nursing | 1 | 2013 | 20 | 0.120 |
Why?
|
Pets | 1 | 2013 | 1 | 0.120 |
Why?
|
Morbidity | 2 | 2011 | 63 | 0.120 |
Why?
|
Needs Assessment | 1 | 2013 | 47 | 0.120 |
Why?
|
Liver Function Tests | 1 | 2012 | 24 | 0.110 |
Why?
|
Cholesterol, HDL | 1 | 2012 | 27 | 0.110 |
Why?
|
Chemical and Drug Induced Liver Injury | 1 | 2012 | 13 | 0.110 |
Why?
|
Child | 3 | 2015 | 1346 | 0.110 |
Why?
|
Creatine Kinase | 1 | 2012 | 33 | 0.110 |
Why?
|
Health Personnel | 1 | 2014 | 115 | 0.110 |
Why?
|
Advanced Practice Nursing | 1 | 2013 | 47 | 0.110 |
Why?
|
Warfarin | 1 | 2012 | 37 | 0.110 |
Why?
|
Exercise Test | 4 | 2005 | 122 | 0.100 |
Why?
|
Anticoagulants | 1 | 2012 | 100 | 0.100 |
Why?
|
Predictive Value of Tests | 2 | 2018 | 521 | 0.100 |
Why?
|
Specialties, Nursing | 1 | 2011 | 10 | 0.100 |
Why?
|
Interdisciplinary Communication | 1 | 2011 | 28 | 0.100 |
Why?
|
Cardiovascular Physiological Phenomena | 1 | 1991 | 6 | 0.100 |
Why?
|
Aged, 80 and over | 6 | 2020 | 4851 | 0.100 |
Why?
|
Homocysteine | 2 | 2007 | 8 | 0.090 |
Why?
|
Protective Factors | 2 | 2021 | 17 | 0.090 |
Why?
|
Sex Factors | 3 | 2018 | 496 | 0.090 |
Why?
|
Oxygen Consumption | 4 | 1997 | 49 | 0.090 |
Why?
|
Patient Protection and Affordable Care Act | 2 | 2020 | 22 | 0.090 |
Why?
|
Quality of Health Care | 4 | 2014 | 138 | 0.090 |
Why?
|
Atrial Fibrillation | 1 | 2012 | 180 | 0.090 |
Why?
|
Early Ambulation | 1 | 1989 | 20 | 0.090 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2009 | 3 | 0.090 |
Why?
|
Nursing Methodology Research | 1 | 2009 | 24 | 0.090 |
Why?
|
Feasibility Studies | 2 | 2020 | 227 | 0.090 |
Why?
|
Societies, Nursing | 1 | 2009 | 21 | 0.090 |
Why?
|
Child, Preschool | 1 | 2011 | 642 | 0.090 |
Why?
|
Feeding Behavior | 1 | 2010 | 100 | 0.090 |
Why?
|
Medication Therapy Management | 2 | 2018 | 4 | 0.090 |
Why?
|
Time Factors | 3 | 2021 | 1616 | 0.090 |
Why?
|
Survival Rate | 1 | 2010 | 349 | 0.080 |
Why?
|
Health Services Needs and Demand | 1 | 2008 | 53 | 0.080 |
Why?
|
Exercise Tolerance | 1 | 2008 | 33 | 0.080 |
Why?
|
Quality Indicators, Health Care | 1 | 2008 | 39 | 0.080 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2020 | 340 | 0.080 |
Why?
|
Drug Monitoring | 2 | 2021 | 24 | 0.080 |
Why?
|
Curriculum | 2 | 2023 | 155 | 0.080 |
Why?
|
Inflammation | 1 | 2010 | 344 | 0.080 |
Why?
|
Muscle Strength | 1 | 2008 | 127 | 0.080 |
Why?
|
Clofibric Acid | 1 | 2006 | 3 | 0.070 |
Why?
|
Alcoholism | 1 | 2007 | 83 | 0.070 |
Why?
|
Metabolic Syndrome | 1 | 2007 | 66 | 0.070 |
Why?
|
Self Report | 2 | 2021 | 218 | 0.070 |
Why?
|
C-Reactive Protein | 1 | 2006 | 125 | 0.070 |
Why?
|
Body Composition | 2 | 2016 | 56 | 0.070 |
Why?
|
Anxiety | 2 | 2018 | 152 | 0.070 |
Why?
|
Activities of Daily Living | 1 | 1989 | 501 | 0.070 |
Why?
|
Body Weight | 2 | 2016 | 133 | 0.070 |
Why?
|
Lipids | 1 | 2005 | 36 | 0.070 |
Why?
|
Young Adult | 3 | 2018 | 1932 | 0.070 |
Why?
|
Comorbidity | 1 | 2006 | 498 | 0.060 |
Why?
|
Cost-Benefit Analysis | 2 | 2015 | 144 | 0.060 |
Why?
|
Incidence | 1 | 2006 | 756 | 0.060 |
Why?
|
Nurse Practitioners | 2 | 2016 | 105 | 0.060 |
Why?
|
Stress, Psychological | 2 | 2018 | 246 | 0.060 |
Why?
|
Depression | 2 | 2018 | 465 | 0.060 |
Why?
|
Cooperative Behavior | 1 | 2023 | 87 | 0.050 |
Why?
|
Risk | 1 | 2003 | 217 | 0.050 |
Why?
|
Lipoproteins | 1 | 2001 | 11 | 0.050 |
Why?
|
United States Department of Defense | 1 | 2021 | 2 | 0.050 |
Why?
|
United States Department of Veterans Affairs | 1 | 2021 | 7 | 0.050 |
Why?
|
Postmenopause | 1 | 2001 | 61 | 0.050 |
Why?
|
Clinical Competence | 2 | 2014 | 230 | 0.050 |
Why?
|
Organizational Culture | 1 | 2021 | 19 | 0.050 |
Why?
|
Follow-Up Studies | 3 | 2017 | 1830 | 0.050 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2020 | 65 | 0.050 |
Why?
|
Coronary Circulation | 1 | 2020 | 43 | 0.050 |
Why?
|
Listeria monocytogenes | 1 | 1999 | 5 | 0.050 |
Why?
|
Listeriosis | 1 | 1999 | 5 | 0.050 |
Why?
|
Gene Expression Regulation, Bacterial | 1 | 1999 | 9 | 0.050 |
Why?
|
Leg | 1 | 1999 | 49 | 0.040 |
Why?
|
Analysis of Variance | 2 | 1997 | 321 | 0.040 |
Why?
|
Regression Analysis | 2 | 1997 | 298 | 0.040 |
Why?
|
Critical Care | 1 | 2021 | 234 | 0.040 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 138 | 0.040 |
Why?
|
Membrane Proteins | 1 | 1999 | 173 | 0.040 |
Why?
|
Walking | 1 | 2020 | 252 | 0.040 |
Why?
|
Health Status Disparities | 1 | 2018 | 69 | 0.040 |
Why?
|
Memory Disorders | 1 | 2019 | 174 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2018 | 75 | 0.040 |
Why?
|
Perception | 1 | 2018 | 83 | 0.040 |
Why?
|
Telephone | 1 | 2017 | 27 | 0.040 |
Why?
|
Heart Rate | 2 | 1995 | 142 | 0.040 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2020 | 202 | 0.040 |
Why?
|
Mass Screening | 1 | 2018 | 177 | 0.040 |
Why?
|
Social Class | 1 | 2016 | 64 | 0.040 |
Why?
|
Georgia | 1 | 2016 | 12 | 0.040 |
Why?
|
Models, Organizational | 1 | 2016 | 27 | 0.040 |
Why?
|
Hemiplegia | 1 | 1995 | 8 | 0.030 |
Why?
|
Up-Regulation | 1 | 2016 | 174 | 0.030 |
Why?
|
Chromatography, High Pressure Liquid | 1 | 1994 | 36 | 0.030 |
Why?
|
Stress, Physiological | 1 | 1994 | 20 | 0.030 |
Why?
|
Dental Hygienists | 1 | 2014 | 1 | 0.030 |
Why?
|
Pharmacists | 1 | 2014 | 16 | 0.030 |
Why?
|
Data Interpretation, Statistical | 1 | 1994 | 96 | 0.030 |
Why?
|
Pregnancy | 1 | 2015 | 403 | 0.030 |
Why?
|
Models, Educational | 1 | 2014 | 36 | 0.030 |
Why?
|
Education, Medical | 1 | 2014 | 49 | 0.030 |
Why?
|
Social Networking | 1 | 2013 | 10 | 0.030 |
Why?
|
Efficiency | 1 | 2013 | 15 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2014 | 91 | 0.030 |
Why?
|
Cats | 1 | 2013 | 76 | 0.030 |
Why?
|
Hemodynamics | 1 | 2013 | 83 | 0.030 |
Why?
|
Cerebrovascular Disorders | 1 | 1995 | 132 | 0.030 |
Why?
|
Propranolol | 1 | 1992 | 12 | 0.030 |
Why?
|
Diagnosis, Differential | 1 | 1994 | 389 | 0.030 |
Why?
|
Interviews as Topic | 1 | 2013 | 130 | 0.030 |
Why?
|
Dogs | 1 | 2013 | 253 | 0.030 |
Why?
|
Rest | 1 | 1992 | 32 | 0.030 |
Why?
|
Survival Analysis | 1 | 2013 | 298 | 0.030 |
Why?
|
Administration, Oral | 1 | 2012 | 140 | 0.030 |
Why?
|
Physicians | 1 | 2014 | 115 | 0.030 |
Why?
|
Data Collection | 1 | 2012 | 107 | 0.030 |
Why?
|
Chronic Disease | 1 | 1994 | 495 | 0.030 |
Why?
|
Foundations | 1 | 2011 | 3 | 0.030 |
Why?
|
Signal Transduction | 1 | 1994 | 482 | 0.030 |
Why?
|
Statistics as Topic | 1 | 2011 | 113 | 0.030 |
Why?
|
Energy Metabolism | 1 | 1991 | 52 | 0.020 |
Why?
|
Reperfusion | 1 | 1989 | 7 | 0.020 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2011 | 194 | 0.020 |
Why?
|
Monitoring, Physiologic | 1 | 1989 | 92 | 0.020 |
Why?
|
Stroke | 1 | 2012 | 293 | 0.020 |
Why?
|
Arm | 1 | 2008 | 78 | 0.020 |
Why?
|
Retrospective Studies | 1 | 2016 | 3273 | 0.020 |
Why?
|
Blood Glucose | 1 | 2007 | 112 | 0.020 |
Why?
|
Rotator Cuff | 1 | 2008 | 265 | 0.020 |
Why?
|
Aging | 1 | 1994 | 1593 | 0.020 |
Why?
|
Animals | 1 | 2013 | 4552 | 0.020 |
Why?
|
Leucine | 1 | 1999 | 15 | 0.010 |
Why?
|
Sequence Alignment | 1 | 1999 | 22 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 1999 | 193 | 0.010 |
Why?
|
Molecular Sequence Data | 1 | 1999 | 246 | 0.010 |
Why?
|
Bacterial Proteins | 1 | 1999 | 76 | 0.010 |
Why?
|
Body Mass Index | 1 | 2001 | 428 | 0.010 |
Why?
|
Sensation | 1 | 1995 | 17 | 0.010 |
Why?
|
Blood Pressure Determination | 1 | 1992 | 20 | 0.010 |
Why?
|
Reproducibility of Results | 1 | 1992 | 788 | 0.010 |
Why?
|